# Syncromune® Inc\.: Now Enrolling LEGION\-100 Trial for mCRPC

> Syncromune® is developing SYNC\-T®, a platform immunotherapy designed to synchronize the location of 3 key components needed to educate the immune system to recognize and attack cancer\. Now enrolling LEGION\-100 trial for metastatic castration\-resistant prostate cancer\. www\.legion100trial\.com

Generated by Yoast SEO v28.1, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Home](https://syncromune.com/)
- [News \& Events](https://syncromune.com/news-events/)
- [Company and Leadership](https://syncromune.com/company-and-leadership/)
- [Science](https://syncromune.com/science/)
- [Patients](https://syncromune.com/patients/)

## Posts
- [Syncromune® Presents Multi\-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium](https://syncromune.com/2026/06/17/syncromune-presents-multi-modal-efficacy-assessment-framework-at-inaugural-gustave-roussy-intratumoral-immunotherapy-symposium/)
- [Syncromune®, Inc\. Presents Innovative SYNC\-T Combination Immunotherapy Approach at Major European Interventional Oncology Conference](https://syncromune.com/2026/04/29/syncromune-inc-presents-innovative-sync-t-combination-immunotherapy-approach-at-major-european-interventional-oncology-conference/)
- [Syncromune Continues to Strengthen Executive and Clinical Leadership with Appointment of Dr\. Stephen P\. Dale, M\.D\., as Chief Medical Officer](https://syncromune.com/2026/01/06/syncromune-continues-to-strengthen-executive-and-clinical-leadership-with-appointment-of-dr-stephen-p-dale-m-d-as-chief-medical-officer/)
- [Syncromune®, Inc\. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting](https://syncromune.com/2025/12/04/syncromune-inc-presents-phase-1-data-highlighting-resolution-of-bone-metastases-in-metastatic-prostate-cancer-patients-at-society-of-urological-oncology-26th-annual-meeting/)
- [Syncromune®, Inc\. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting](https://syncromune.com/2025/11/20/syncromune-inc-to-present-phase-1-data-highlighting-resolution-of-bone-metastases-in-metastatic-prostate-cancer-patients-at-the-society-of-urological-oncology-26th-annual-meeting/)

## ElementsKit items
- [dynamic\-content\-widget\-popup\-23580f96](https://syncromune.com/elementskit-content/dynamic-content-widget-popup-23580f96/)
- [dynamic\-content\-widget\-d0152c6\-66f65df](https://syncromune.com/elementskit-content/dynamic-content-widget-d0152c6-66f65df/)
- [dynamic\-content\-widget\-popup\-e8d449f](https://syncromune.com/elementskit-content/dynamic-content-widget-popup-e8d449f/)
- [dynamic\-content\-megamenu\-menuitem5950](https://syncromune.com/elementskit-content/dynamic-content-megamenu-menuitem5950/)
- [dynamic\-content\-megamenu\-menuitem5938](https://syncromune.com/elementskit-content/dynamic-content-megamenu-menuitem5938/)

## Templates
- [Test header](https://syncromune.com/?elementskit_template=test-header)
- [Main Mega](https://syncromune.com/?elementskit_template=main-mega)

## Theme Parts
- [Header for green](https://syncromune.com/?jet-theme-core=header-for-green)
- [FOOTER\-MAIN](https://syncromune.com/?jet-theme-core=footer-main)
- [Bar Mega Menu](https://syncromune.com/?jet-theme-core=bar-mega-menu)
- [Mega Main](https://syncromune.com/?jet-theme-core=mega-main)
- [Header\-Home](https://syncromune.com/?jet-theme-core=header-home)

## Categories
- [News](https://syncromune.com/category/news/)
- [Press Releases](https://syncromune.com/category/press-releases/)
- [2025](https://syncromune.com/category/2025/)
- [2024](https://syncromune.com/category/2024/)
- [2023](https://syncromune.com/category/2023/)

## Optional
- [Sitemap index](https://syncromune.com/sitemap_index.xml)